Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an international Sjögren's syndrome registry

Arthritis Care and Research

Volumn 64, Issue 6, 2012, Pages 911-918

  Malladi, Arundathi S ^a   Sack, Kenneth E ^a   Shiboski, Stephen C ^a   Shiboski, Caroline H ^a   Baer, Alan N ^b   Banushree, Ratukondla ^c   Dong, Yi ^d   Helin, Pekka ^e   Kirkham, Bruce W ^f   Li, Mengtao ^d   Sugai, Susumu ^g   Umehara, Hisanori ^g   Vivino, Frederick B ^h   Vollenweider, Cristina F ⁱ   Zhang, Wen ^d   Zhao, Yan ^d   Greenspan, John S ^a   Daniels, Troy E ^a   Criswell, Lindsey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Aravind Eye Institute   (India)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g KANAZAWA MEDICAL UNIVERSITY   (Japan)

^h PENN PRESBYTERIAN MEDICAL CENTER   (United States)

ⁱ HOSPITAL ALEMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXTRAGLANDULAR MANIFESTATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPOCOMPLEMENTEMIA; KIDNEY DISEASE; LABORATORY TEST; LIVER DISEASE; LYMPHADENOPATHY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIMARY BILIARY CIRRHOSIS; REGISTER; SJOEGREN SYNDROME; SYSTEMIC DISEASE; THYROID DISEASE; VASCULITIS; ASIA; COMORBIDITY; EUROPE; INTERNATIONAL COOPERATION; LYMPHATIC SYSTEM DISEASE; MIDDLE AGED; PREVALENCE; WESTERN HEMISPHERE;

ADULT; AGED; AGED, 80 AND OVER; AMERICAS; ASIA; COMORBIDITY; EUROPE; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; INTERNATIONAL AGENCIES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; SJOGREN'S SYNDROME; VASCULITIS;

EID: 84863218864     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21610     Document Type: Article

References (20)

1. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006;45:187-91.
2. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the united states. Part I. Arthritis Rheum 2008;58:15-25.
3. Talal N, Bunim JJ. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964;36:529-40.
4. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
5. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
6. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
7. Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, et al. Incidence of malignancy in primary Sjögren's syndrome in a Chinese cohort. Rheumatology (Oxford) 2010;49:571-7.
8. Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, Dong Y, et al, for the Sjögren's International Collaborative Clinical Alliance Research Groups. An early view of the International Sjögren's Syndrome Registry. Arthritis Rheum 2009;61:711-4.
9. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992;71:1363-9.
10. Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al, for the Sjögren's International Collaborative Clinical Alliance Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1, 726 registry participants. Arthritis Rheum 2011;63:2021-30.
11. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca: analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994;37:869-77.
12. Van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969;82:10-4.
13. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol 2010;149:405-15.
14. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554-8.
15. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjögren's syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008;87:210-9.
16. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:296-304.
17. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren's syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83:280-91.
18. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005;128:2518-34.
19. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 2007;17:1211-23.
20. Brito-Zeron P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 2007;46:1359-62.